About Department of cardiology, Aarhus University Hospital in Skejby
Aarhus Universitetshospital var tidligere det fælles navn for de tre hospitaler i Aarhus og er med mere end 10.000 ansatte den største hospitalsenhed i Region Midtjylland. Med en udvidelse af sygehuset i Skejby for 6,35 mia. kr. nedlægges Aarhus Sygehus på Nørrebrogade og Tage-Hansens Gade og flyttes til Skejby.
Clinical Trials at Department of cardiology, Aarhus University Hospital in Skejby
During the past decade, Department of cardiology, Aarhus University Hospital in Skejby conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Department of cardiology, Aarhus University Hospital in Skejby" #1 sponsor was "University of Aarhus" with 19 trials, followed by "Aarhus University Hospital Skejby" with 6 trials
sponsored, "Steen Hvitfeldt Poulsen" with 3 trials sponsored, "Aarhus University Hospital" with 2 trials sponsored and "Christian Juhl Terkelsen"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Department of cardiology, Aarhus University Hospital in Skejby"
#1 collaborator was "Aarhus University Hospital" with 5 trials as a collaborator, "Danish Heart Foundation" with 4 trials as a collaborator, "Odense University Hospital" with 4 trials as a collaborator, "Rigshospitalet, Denmark" with 4 trials as a collaborator and "Aalborg University Hospital" with 3 trials as a collaborator. Other collaborators include 31 different institutions and companies that were
collaborators in the rest 37 trials.
Clinical Trials Conditions at Department of cardiology, Aarhus University Hospital in Skejby
According to Clinical.Site data, the most researched conditions in "Department of cardiology, Aarhus University Hospital in Skejby" are
"Heart Failure" (3 trials), "Myocardial Infarction" (3 trials), "Pulmonary Hypertension" (3 trials), "Angiography" (2 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Department of cardiology, Aarhus University Hospital in Skejby" in a lesser frequency.
Clinical Trials Intervention Types at Department of cardiology, Aarhus University Hospital in Skejby
Most popular intervention types in "Department of cardiology, Aarhus University Hospital in Skejby" are "Procedure" (11 trials), "Drug" (5 trials), "Device" (4 trials), "Other" (4 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "AAIR/DDDR pacemaker" (1 trials), "Accelerated, combined biomarker rule-out strategy for MI" (1 trials), "Acute CAG" (1 trials) and "Bisoprolol" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Department of cardiology, Aarhus University Hospital in Skejby
The vast majority of trials in "Department of cardiology, Aarhus University Hospital in Skejby" are
36 trials for "All" genders.
Clinical Trials Status at Department of cardiology, Aarhus University Hospital in Skejby
Currently, there are NaN active trials in "Department of cardiology, Aarhus University Hospital in Skejby".
1 are not yet recruiting,
5 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 20 completed trials in Department of cardiology, Aarhus University Hospital in Skejby,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Department of cardiology, Aarhus University Hospital in Skejby, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 17 trials that are defined as “Not Applicable".